Milad Nazari

Milad Nazari, PhD, MBA, serves as Associate Director of Business Development & Acquisitions at AbbVie, where responsibilities include co-leading sell-side projects for divesting deprioritized assets and supporting in-licensing initiatives. Previously, Milad participated in AbbVie's two-year Strategy Leadership Program, focusing on long-range strategic development and partnership optimization. With a strong analytical background, Milad led a team responsible for testing small-molecule APIs in toxicology studies and directed analytical efforts for various project phases. Earlier academic contributions at North Carolina State University involved leading research on lipidome and metabolome aberrations in ovarian cancer, alongside substantial roles in method development and instrument training in mass spectrometry. Milad holds a PhD in Chemistry, an MBA in Leadership in Finance, and a BS in Chemistry, complemented by an AS in Pre-Engineering.